Its cost-effective
Eligibility includes: [4] BMI 27 with cardiovascular disease history BMI 30 with comorbidities BMI 35 Timeline: Interim program July 2026, Part D coverage January 2027 Savings Programs NovoCare Savings Card: Eligible commercially insured patients may pay as little as $25/month if their plan covers Wegovy (max savings $225/month)
Danysz, W., Essmann, U., Bresink, I
If you live with type 1 diabetes, chances are you've heard about GLP-1 medications Ozempic, Wegovy, Mounjaro mostly in the context of weight loss or type 2 diabetes
Indeed, a 2022 study found that after stopping a regimen of Semaglutide, the active ingredient in Ozempic, patients regained 2/3rds of the weight loss within one year
Studies have shown that semaglutide injections can improve glycemic control in users, helping keep blood sugar levels steady throughout the day